CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-17 | KIDRON NADAV President and CEO | Grant or award | +279,000 | 1,332,098 | ||
| 2023-04-17 | Rozov Yadin Director | Grant or award | +30,000 | 116,500 | ||
| 2023-04-17 | Kidron Miriam Chief Scientific Officer | Grant or award | +213,000 | 414,666 | ||
| 2023-04-17 | Silberman David Chief Financial Officer | Grant or award | +97,500 | 205,500 | ||
| 2023-04-17 | Mayer Arie Director | Grant or award | +30,000 | 56,809 | ||
| 2023-04-04 | Mayer Arie Director | Purchase | +3,800 | $2.21 | $8K | 26,809 |
| 2023-04-03 | Mayer Arie Director | Purchase | +5,009 | $2.22 | $11K | 23,009 |
| 2023-03-16 | KIDRON NADAV President and CEO | Purchase | +26,000 | $2.04 | $53K | 126,000 |
| 2023-03-14 | KIDRON NADAV President and CEO | Purchase | +100,000 | $2.01 | $201K | 100,000 |
| 2023-03-14 | Kidron Miriam Chief Scientific Officer | Sale | −100,000 | $2.01 | $201K | 201,666 |
| 2023-03-14 | Rozov Yadin Director | Purchase | +50,000 | $2.05 | $102K | 86,500 |
| 2023-03-13 | Rozov Yadin Director | Purchase | +20,000 | $1.96 | $39K | 36,500 |
| 2023-01-03 | Rabinowitz Michael Chief Commercial Officer | Sale | −1,425 | $13.01 | $19K | 138,043 |
| 2023-01-03 | Rabinowitz Michael Chief Commercial Officer | Sale | −11,900 | $12.49 | $149K | 126,143 |
| 2022-10-27 | KIDRON NADAV President and CEO | Gift | −25,000 | 1,053,098 | ||
| 2022-08-08 | Sank Leonard Director | Option exercise | +20,000 | $4.08 | $82K | 38,000 |
| 2022-08-08 | Sank Leonard Director | Shares withheld for taxes | −9,304 | $8.77 | $82K | 28,696 |
| 2022-08-08 | Sank Leonard Director | Option exercise · Stock Option | −20,000 | 0 | ||
| 2022-08-01 | KIDRON NADAV President and CEO | Shares withheld for taxes | −12,631 | $8.36 | $106K | 1,078,098 |
| 2022-07-28 | Rozov Yadin Director | Grant or award | +12,000 | 16,500 |
Page 7 of 9 · 170 trades